Articles tagged with: antiretroviral therapy (ART)

Is the end of HIV in sight? Yes! And no.

published: March, 27, 2018 Written by // Jeff Potts Categories // Social Media, As Prevention , Gay Men, Current Affairs, Treatment Guidelines -including when to start, Health, Sexual Health, Treatment, Media, Opinion Pieces, Jeff Potts

In which Jeff Potts checks in and introduces a brilliant article, "Is the End of HIV In Sight? Yes! And No" by his brother, David.

Is the end of HIV in sight? Yes! And no.

Several weeks of intensely meaningful engagement, and then this… by Jeff Potts I muse, as I tidy up this third and final draft, that it is a bit odd for a guy who lives with HIV and who works in the HIV sector (almost always has) to reflect on and write about a few weeks of full-on HIV engagement immersion.  But, that’s the truth of it.  I’m a bit weary this Monday morning as we near the end of March (and fiscal year-end).  It’s a good weary though.  A weary that reminds me tha

New HIV infections halved after scale-up of HIV treatment, circumcision, in Uganda's hardest-hit district

published: March, 08, 2018 Written by // Guest Authors - Revolving Door Categories // Social Media, African, Caribbean and Black, As Prevention , Current Affairs, Treatment Guidelines -including when to start, Health, International , Revolving Door, Treatment, Media, Guest Authors

From AIDSmap, Michael Carter and Keith Alcorn report on the Rakai Community Cohort Study.

New HIV infections halved after scale-up of HIV treatment, circumcision, in Uganda's hardest-hit district

The rate of new HIV infections has halved since 2011 in a Ugandan community following large increases in male circumcision, antiretroviral treatment and viral suppression, Frank Kagaayi of the Rakai Health Sciences Program told the Conference on Retroviruses and Opportunistic Infections in Boston on Tuesday. Dr Kagaayi was presenting results from the Rakai Community Cohort Study, focusing on repeat surveys of one fishing village with a very high prevalence and incidence of HIV infection. The

Undetectable viral load is a milestone in this journey.

published: March, 05, 2018 Written by // Kimutai Kemboi, Categories // African, Caribbean and Black, Social Media, Activism, As Prevention , Kimutai Kemboi, Treatment Guidelines -including when to start, Health, International , Treatment, Living with HIV, Media

From Kenya, Kimutai Kemboi spreads the word that undetectable equals untransmittable

Undetectable viral load is a milestone in this journey.

I had a conversation with this guy, Sammy (not his real name) and I feel I should share it so that other people learn the facts. Sammy: Hi Kim? (the short name of Kimutai) Kemboi: Hi to you bro, how is the going? Sammy: All is well, how about you? Kemboi: Everything is perfect, just up and down as a routine. Sammy: There is something that has been disturbing my mind for a while now and I have tried asking and researching but I am not convinced by the responses. That is why I thought of a

Chronic depression leads to poorer engagement with key stages of HIV care continuum, say US researchers

published: February, 28, 2018 Written by // Guest Authors - Revolving Door Categories // Social Media, Mental Health, Research, Health, International , Revolving Door, Media, Guest Authors

From AIDSmap, Michael Carter reports on a study designed to examine the association between chronic depression and clinical outcomes.

Chronic depression leads to poorer engagement with key stages of HIV care continuum, say US researchers

Increased time spent living with depression is associated with poorer engagement with the HIV care continuum, investigators from the United States report in JAMA Psychiatry. Chronic depression was associated with missing appointments, a detectable viral load and an increased mortality risk. “We found that a greater proportion of time spent with depression increased the risk of missed primary care appointments and lack of viral suppression in a dose-response manner,” comment the autho

HIV treatment is not only a life giver but a life saver.

published: February, 16, 2018 Written by // Guest Authors - Revolving Door Categories // Social Media, African, Caribbean and Black, As Prevention , Current Affairs, Treatment Guidelines -including when to start, Health, International , Lifestyle, Revolving Door, Treatment, Living with HIV, Guest Authors, Media, Opinion Pieces

From Uganda, Matovu William's first article as a regular contributor to PositiveLite.com discusses the many benefits of antiretroviral theraoy (ART).

HIV treatment is not only a life giver but a life saver.

According to UNAIDS, there were approximately 36.7 million people worldwide living with HIV/AIDS at the end of 2016. Of these, 2.1 million were children (<15 years old). As of July 2017, 20.9 million people living with HIV were accessing antiretroviral therapy (ART) globally, up from 15.8 million in June 2015, 7.5 million in 2010, and less than one million in 2000. HIV treatment known as Antiretroviral Therapy (ART) is medication which is given to HIV positive people to treat HIV but it do

Will de-simplification of HIV treatment become common in high-income countries?

published: February, 14, 2018 Written by // CATIE - HIV and Hep C Info Resource Categories // Social Media, As Prevention , Treatment Guidelines -including when to start, Research, CATIE - HIV and Hep C Info Resource, Treatment, Media

From CATIE, Sean R. Hosein reports on a study exploring de-simplification as a cost-cutting measure.

Will de-simplification of HIV treatment become common in high-income countries?

- As more people start HIV treatment, researchers are exploring ways to cut costs - Single tablets can be replaced by a few pills comprising cheaper generic drugs - Alberta clinic projects $4.3 million saved by “de-simplifying” one treatment regimen Initiating and staying on HIV treatment (ART) results in most people having very low levels of HIV in their blood. Such low levels are commonly called undetectable and result in improved measures of health and projections of near-normal life

Generic drugs for HIV treatment may save money, but barriers to prescription make savings elusive

published: February, 08, 2018 Written by // Guest Authors - Revolving Door Categories // Social Media, As Prevention , Current Affairs, Treatment Guidelines -including when to start, Research, Health, International , Revolving Door, Treatment, Media, Guest Authors

Scepticism among healthcare providers, patients and pharmacists about the safety and efficacy of generic medications is an important barrier. From AIDSmap, Keith Alcorn reports.

Generic drugs for HIV treatment may save money, but barriers to prescription make savings elusive

The potential savings from prescribing generic antiretrovirals predicted by economic models may be overstated and numerous barriers need to be overcome to bring down the cost of HIV treatment in higher-income countries, according to the findings of several recently-published analyses. Switching to cheaper generic versions of some antiretrovirals has been proposed as a means of freeing up money to treat more people with HIV in the United States and other higher-income countries where generics

Many Americans still get their HIV diagnosis years after infection

published: December, 07, 2017 Written by // Guest Authors - Revolving Door Categories // Social Media, As Prevention , Gay Men, Treatment Guidelines -including when to start, Research, Health, International , Revolving Door, Treatment, Media, Guest Authors

Heterosexual men had undiagnosed HIV longer than women who inject drugs or gay and bisexual men (a median of about five years, two years and three years, respectively).From AIDSmap, Liz Highleyman reports.

Many Americans still get their HIV diagnosis years after infection

Many people with HIV in the United States are still being diagnosed with HIV late, and therefore not getting the full therapeutic and prevention benefits of starting antiretroviral therapy (ART) early, according to the latest Vital Signs report from the US Centers for Disease Control and Prevention (CDC), released in advance of World AIDS Day. People at risk for HIV in the US are getting tested more often than they did in the past and are living with HIV for a shorter period of time bef

Starting ART immediately after HIV diagnosis cuts mortality risk by two-thirds for people with high CD4 cell counts

published: November, 08, 2017 Written by // Guest Authors - Revolving Door Categories // Social Media, As Prevention , Treatment Guidelines -including when to start, General Health, Health, International , Revolving Door, Treatment, Media, Guest Authors

Over 12 months of follow-up, individuals who started antiretrovirals within 30 days of their diagnosis had a 63% reduction in their mortality risk compared to people who remained antiretroviral-naïve. From AIDSmap, Michael Carrter reports.

Starting ART immediately after HIV diagnosis cuts mortality risk by two-thirds for people with high CD4 cell counts

People with a high CD4 cell count who start antiretroviral therapy (ART) immediately after diagnosis with HIV cut their 12-month mortality risk by two-thirds, according to research conducted in China and published in Clinical Infectious Diseases. The retrospective study involved over 35,000 people who were newly diagnosed with HIV between 2012 and 2014. All had a CD4 cell count above 500 cells/mm3. Over 12 months of follow-up, individuals who started antiretrovirals within 30 days of their d

Investigating where patients go when they leave HIV care

published: November, 06, 2017 Written by // CATIE - HIV and Hep C Info Resource Categories // Social Media, As Prevention , CATIE, Treatment Guidelines -including when to start, General Health, Research, International , Sexual Health, Treatment, Living with HIV, Media

From CATIE, Sean R. Hosein reports on research that begins to paint a picture of what happens when people living with HIV are "lost to follow-up."

Investigating where patients go when they leave HIV care

- Previous research has found HIV-positive Canadians stop attending follow-up HIV appointments at rates between 11% and 24%. - Alberta researchers find that many patients “lost to follow-up” are seeking healthcare outside HIV services, often in hospital emergency rooms. - This research has implications for programs that seek to re-engage patients in HIV care. Potent combination anti-HIV therapy (ART) can reduce levels of HIV in the blood (viral load) to very low levels that cannot be de

[12 3 4 5  >>